Trial intelligence / Profile preview

MTA Versus Biodentine for Pulpotomy in Immature Permanent Molars

NCT03838094Phase 2Completed

Start: Feb 2016
Primary completion: Aug 2018

Overview

Phase 2, randomised, single-blind trial (2 arms). Primary endpoints: Pain, sensitivity to percussion/palpation at 18 months, Swelling or sinus tract at 18 months and 1 more. Started Feb 2016; status: completed.

Beyond the preview

Go deeper on NCT03838094.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03838094.